Treatment of Diabetes with Insulin

Diabetes in Clinical Practice: Questions and Answers from Case Studies

Volumn , Issue , 2006, Pages 371-408

  Liatis, Stavros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Basal bolus insulin regimen application; Insulin analogues and insulin bioavailability; Insulin therapy types; Most preferable 'prandial' insulin; Treating diabetes with insulin

Indexed keywords

EID: 84885815881     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059142.ch28     Document Type: Chapter

References (17)

1. Barnett, A.H. (2003) A review of basal insulins. Diabet Med 20: 873-85.
2. Bolli, G.B. (1997) Insulin treatment and its complications, in Textbook of Diabetes 2nd edn, (eds J. Pickup and G. Williams), Oxford, 43: pp. 1-38.
3. Chan, J.L., Abrahamson, M.J. (2003) Pharmacological management of Type 2 diabetes mellitus: Rationale for rational use of insulin. Mayo Clin Proc 78: 459-67.
4. Davidson, M.B. (2005) Starting insulin therapy in Type 2 diabetic patients: Does it really matter how? Diabetes Care 28: 494-5.
5. De Witt, D.E., Hirsch, I.B. (2003) Outpatient insulin therapy in Type 1 and Type 2 diabetes mellitus. Scientific review. JAMA 289: 2254-64.
6. De Witt, D.E., Dugdale, D.C. (2003) Using new insulin strategies in the outpatient treatment of diabetes. Clinical applications. JAMA 289: 2265-69.
7. Diabetes Control and Complications Trial Research Group (DCCT) (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med., 329: 977-86.
8. Gerich, J.E. (2002) Novel insulins: expanding options in diabetes management. Am J Med 113: 308-16.
9. Heinemann, L. (1997) Insulin pharmacology, in Textbook of Diabetes 2nd edn, (eds J. Pickup and G. Williams), Oxford, 42:pp. 1-15.
10. Home, P., Bartley, P., Russell-Jones, D., Hanaire-Broutin, H., Heeg, J.E., Abrams, P., Landin-Olsson, M., Hylleberg, B., Lang, H., Draeger, E. (2004) Insulin Detemir offers improved glycemic control compared with NPH insulin in patients with Type 1 diabetes. Diabetes Care 27: 1081-87.
11. Janka, H.U., Riddle, M.C., Kliebe-Frisch, C., Schweitzer, M.A., Yki-Järvinen. (2005) Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for Type 2 diabetes. Diabetes Care 28: 254-9.
12. Raskin, P., Allen, E., Hollander, P., Lewin, A., Gabbay, R.A., Hu, P., Bode, B., Garber, A. (2005) (for the INITIATE Study Group) Initiating Insulin Therapy in Type 2 Diabetes: A comparison of biphasic and basal insulin analogs. Diabetes Care 28: 260-5.
13. Ratner, R.E., Hirsch, I.B., Neifing, J.L., Garg, S.K., Mecca, T.E., Wilson, C.A. (2000) Less hypoglycemia with insulin Glargine in intensive insulin therapy for Type 1 diabetes. Diabetes Care 23: 639-43.
14. Skyler, J.S. (2004) Insulin treatment, in Therapy for Diabetes Mellitus and Related Disorders, 4th edn. American Diabetes Association, (ed. H.E. Lebovitz) pp. 207-23.
15. UKPDS Study Group (1998). Intensive blood glucose control with sulfonylurea or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet, 352, 837-53.
16. Yki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R., Heikkilä, M. (1999) Comparison of bedtime insulin regimens in patients with Type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 130: 389-96.
17. Yki-Järvinen, H. (2001) Combination therapies with insulin in Type 2 diabetes. Diabetes Care 24: 758-67.